|
"yen fs"的相關文件
顯示項目 76-85 / 90 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2020-01-21 |
Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes
|
Yen, FS;Yang, YC;Hwu, CM;Wei, JC;Huang, YH;Hou, MC;Hsu, CC |
| 中山醫學大學 |
2020 |
Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout
|
Yen, FS; Hsu, CC; Li, HL; Wei, JCC; Hwu, CM |
| 中山醫學大學 |
2020 |
The factors associated with insulin nonpersistence in persons with type 2 diabetes
|
Yen, FS; Wei, JCC; Liu, JS; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2020 |
Liver-related long-term outcomes of thiazolidinedione use in persons with type 2 diabetes
|
Yen, FS; Yang, YC; Hwu, CM; Wei, JCC; Huang, YH; Hou, MC; Hsu, CC |
| 中山醫學大學 |
2020 |
Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
|
Yen, FS; Lai, JN; Wei, JCC; Chiu, LT; Hwu, CM; Hou, MC; Hsu, CC |
| 中山醫學大學 |
2020 |
Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus
|
Yen, FS; Wang, HC; Pan, CW; Wei, JCC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2020 |
Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
|
Yen, FS; Wei, JCC; Yang, YC; Hsu, CC; Hwu, CM |
| 中山醫學大學 |
2020 |
Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout
|
Yen, FS; Hsu, CC; Li, HL; Wei, JCC; Hwu, CM |
| 國家衛生研究院 |
2019-09-23 |
Pioglitazone exposure reduced the risk of all-cause mortality in insulin-treated patients with type 2 diabetes mellitus
|
Yen, FS;Wang, HC;Pan, CW;Wei, JC;Hsu, CC;Hwu, CM |
| 國家衛生研究院 |
2019-01 |
All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes
|
Yen, FS;Chiang, JH;Hwu, CM;Yen, YH;Lin, BJ;Wei, JCC;Hsu, CC |
顯示項目 76-85 / 90 (共9頁)
<< < 1 2 3 4 5 6 7 8 9 > >>
每頁顯示[10|25|50]項目
|
